Health Canada Issues Guides on Tougher Drug Shortage Reporting Rules

by admin
Health Canada Issues Guides on Tougher Drug Shortage Reporting Rules

Health Canada published four guides on its drug shortage rules, which require most discontinuations to be reported at least 12 months ahead.

Health Canada has published four new and updated guides that explain how drug companies must meet its tougher drug shortage rules. The rules already apply, and companies must now report most planned discontinuations at least 12 months ahead.

The guides were released on Oct. 16, 2026, in Health Canada’s Drug Establishment Licensing Bulletin 1981. They cover shortage and discontinuation reporting, emergency imports of substitute drugs, exports, and longer expiry dates. A virtual information session for companies is set for Oct. 21, 20261.

At a glanceDetails
What was publishedFour guidance documents on amended drug shortage rules
Published on16 October 2026
Who must complyDrug makers holding a drug identification number, and holders of establishment licences
Effective dateRules in force since 17 June 2026
Next milestoneVirtual information session on 21 October 2026

What is new in this release?

The underlying rules are not new. Health Canada published the amended regulations, numbered SOR/2026-96, in the Canada Gazette on June 17, 2026, and they took effect that day1. The Gazette, Canada’s official record of new regulations, lists them as registered on May 29, 20262.

What is new is the practical guidance. Health Canada says the documents help regulated companies meet the requirements in the Food and Drug Regulations1. The four guides are:

  • GUI-0120: reporting and providing information on drug shortages and discontinuations
  • GUI-0148: exceptional importation and sale of drugs in response to shortages and discontinuations
  • GUI-0145: distributing drugs meant for the Canadian market for use outside Canada
  • GUI-0500: extending expiration dates of marketed drugs during shortages

The department says the regulations aim to protect people in Canada from the harm caused by health product shortages1.

Earlier notice of discontinued drugs

The biggest change for drug makers is timing. A company that decides to stop selling a drug more than 12 months out must post notice at least 12 months before the stop date2. If the stop date is 12 months away or less, it must post notice within five days of the decision2.

Notices go on a designated public website, in both English and French2. If posted details change, the company must update them within five days2.

A separate rule covers drugs that simply stop selling. If a maker has not sold a drug for 12 months, it must tell the health minister in writing within 30 days2.

SituationWhat the company must do
Stop date more than 12 months awayPost notice at least 12 months before
Stop date 12 months away or lessPost notice within 5 days of deciding
Discontinuation details changeUpdate within 5 days
Drug not sold for 12 monthsNotify the minister within 30 days

Shortage reporting and a wider list of drugs

When a shortage exists or is likely, the maker must post details on the designated website2. If it expects a shortage to begin within six months, it must post within five days of that finding2. It must update changed details within two days, and post within two days once it can meet demand again2.

The rules also widen which drugs are covered. Health Canada can now add drugs such as over-the-counter medicines to an Expanded Scope List1. It can do so when a shortage or discontinuation of those drugs could risk injury to human health1. Listed drugs then face the same shortage reporting rules and limits on sales outside Canada1.

Health Canada may also ask makers and licence holders for information when a shortage could risk health2. They must answer in the time and manner the minister sets2.

Emergency imports to fill gaps

The exceptional importation framework lets licensed companies bring in foreign-approved drugs during a shortage. The amended rules widen it in three ways1:

  • Drugs made in Canada but approved only abroad may now be sold at home.
  • Imports are allowed for more shortages, including over-the-counter drugs, where health is at risk.
  • A substitute drug can be imported for up to 36 months after a Canadian drug is discontinued.

An importer must notify the minister at least three business days before the drug arrives2. Health Canada can limit sales of listed drugs to named health professionals and licence holders1. Sellers must give users safe-use information at the time of sale1. They must also report serious adverse drug reactions and certain foreign actions such as recalls1.

Longer expiry dates during shortages

A new framework lets Health Canada extend the expiry dates of specific drug lots or batches1. It applies when a shortage, or risk of one, could harm human health1. Those lots go on an Extended Expiration Date List, and may be sold until the new date1.

Exports and record keeping

Licence holders who ship drugs for use outside Canada face a record-keeping duty. They must immediately create a detailed record of the information showing the export is not prohibited2. Guide GUI-0145 covers this area1.

Key terms in plain words

TermMeaning
Drug identification numberThe number Health Canada assigns to each drug approved for sale
DiscontinuationWhen a maker permanently stops selling a drug in Canada
Establishment licenceA Health Canada licence to make, import or distribute drugs
Exceptional importationBringing in a foreign-approved drug to cover a Canadian shortage
Expanded Scope ListHealth Canada’s list of extra drugs brought under shortage rules
Canada GazetteThe government’s official publication for new regulations

Health Canada’s Health Product Shortages Directorate will hold its virtual information session on Oct. 21, 2026, from 2:30 p.m. to 3:30 p.m. EST1.

Sources

  1. ↩ New and updated guidance documents on drug shortages – Canada.ca https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/establishment-licences/drug-establishment-licensing-bulletin/new-updated-guidance-documents-drug-shortages.html
  2. ↩ Canada Gazette, Part 2, Volume 160, Number 12: Regulations Amending Certain Regulations Made Under the Food and Drugs Act (Shortages and Discontinuation of Sale of Drugs and Medical Devices) https://gazette.gc.ca/rp-pr/p2/2026/2026-06-17/html/sor-dors96-eng.html

You may also like